National Center for Cancer Care & Research (NCCCR)
About National Center for Cancer Care & Research (NCCCR)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at National Center for Cancer Care & Research (NCCCR)
During the past decade, National Center for Cancer Care & Research (NCCCR) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
2020-03-15
2020-06-26
Completed
1,113
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)
2020-03-06
2020-06-30
Completed
4,891
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at National Center for Cancer Care & Research (NCCCR)
According to Clinical.Site data, the most researched conditions in "National Center for Cancer Care & Research (NCCCR)" are
"Essential Thrombocythemia" (2 trials), "Primary Myelofibrosis, Fibrotic Stage" (2 trials), "Primary Myelofibrosis, Prefibrotic Stage" (2 trials), "Chronic Myeloid Leukemia - Chronic Phase" (1 trials) and "Osteoporosis" (1 trials). Many other conditions were trialed in "National Center for Cancer Care & Research (NCCCR)" in a lesser frequency.
Clinical Trials Intervention Types at National Center for Cancer Care & Research (NCCCR)
Most popular intervention types in "National Center for Cancer Care & Research (NCCCR)" are "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Diagnostic (18F-FLT PET/CT)" (2 trials), "Dasatinib 100 MG [Sprycel]" (1 trials), "Denosumab 60 MG/ML Prefilled Syringe" (1 trials), "Nilotinib 150mg oral capsule [Tasigna]" (1 trials) and "Zoledronic Acid 5Mg/Bag 100Ml Inj" (1 trials). Other intervention names were less common.
Clinical Trials Genders at National Center for Cancer Care & Research (NCCCR)
The vast majority of trials in "National Center for Cancer Care & Research (NCCCR)" are
4 trials for "All" genders.
Clinical Trials Status at National Center for Cancer Care & Research (NCCCR)
Currently, there are NaN active trials in "National Center for Cancer Care & Research (NCCCR)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in National Center for Cancer Care & Research (NCCCR),
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in National Center for Cancer Care & Research (NCCCR), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".